Insider Transactions in Q1 2023 at Biora Therapeutics, Inc. (BIOR)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 15
2023
|
Clarke Neumann |
SELL
Payment of exercise price or tax liability
|
Direct |
10,683
-10.55%
|
$21,366
$2.56 P/Share
|
Mar 15
2023
|
Clarke Neumann |
BUY
Grant, award, or other acquisition
|
Direct |
79,634
+29.89%
|
-
|
Mar 15
2023
|
Eric D Esparbes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,216
-9.92%
|
$22,432
$2.56 P/Share
|
Mar 15
2023
|
Eric D Esparbes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
84,917
+28.75%
|
-
|
Mar 15
2023
|
Aditya P. Mohanty Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
22,252
-7.12%
|
$44,504
$2.56 P/Share
|
Mar 15
2023
|
Aditya P. Mohanty Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,429
+24.66%
|
-
|
Feb 15
2023
|
Eric D Esparbes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
269
-0.95%
|
$807
$3.46 P/Share
|
Feb 15
2023
|
Clarke Neumann |
SELL
Payment of exercise price or tax liability
|
Direct |
84
-0.39%
|
$252
$3.46 P/Share
|
Jan 03
2023
|
Athyrium Opportunities Iii Co Invest 1 LP |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
42,362
-100.0%
|
-
|
Jan 03
2023
|
Jill Ann Howe |
SELL
Sale (or disposition) back to the issuer
|
Direct |
19
-100.0%
|
-
|
Jan 03
2023
|
Eric D Esparbes Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
95
-100.0%
|
-
|
Jan 03
2023
|
Surbhi Sarna Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8
-100.0%
|
-
|
Jan 03
2023
|
Jeffrey D. Alter |
SELL
Sale (or disposition) back to the issuer
|
Direct |
65
-100.0%
|
-
|
Jan 03
2023
|
Lynne Powell |
SELL
Sale (or disposition) back to the issuer
|
Direct |
45
-100.0%
|
-
|
Jan 03
2023
|
Clarke Neumann |
SELL
Sale (or disposition) back to the issuer
|
Direct |
44
-100.0%
|
-
|
Jan 03
2023
|
Aditya P. Mohanty Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
178
-100.0%
|
-
|
Jan 03
2023
|
Brian L. Kotzin |
SELL
Sale (or disposition) back to the issuer
|
Direct |
44
-100.0%
|
-
|